Andere talen DiaMedica Therapeutics Inc.

Aandelen

DMAC

CA25253X2077

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 13-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,19 ^USD	+2,24%		-8,86%	+12,32%

09/05	Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024
17/04	DiaMedica Therapeutics Inc. kondigt aan dat de eerste patiënt gedoseerd is in de herstart van de cruciale Fase 3/3 ReMEDy2-studie met DM199 voor de behandeling van acute ischemische beroerte	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results	08/05
DiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024	02/05
DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment	17/04
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke	17/04
DiaMedica Therapeutics Inc. Announces First Patient Dosed in Relaunch of Its Pivotal Phase /3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke	17/04
DiaMedica Therapeutics Inc. Announces Executive Changes	10/04
DiaMedica Therapeutics Files $100 Million Mixed Shelf	21/03
DiaMedica Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results	19/03
DiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference	29/01
DiaMedica Therapeutics Names Lorianne Masuoka as Chief Medical Officer	22/01
DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer	22/01
DiaMedica Therapeutics Inc. Appoints Dr. Lorianne Masuoka as Chief Medical Officer	22/01
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results	13/11
DiaMedica Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023	09/11
DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023	06/11
Top Premarket Gainers	25-10-23
DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer	12-09-23
DiaMedica Therapeutics Inc. Announces the Appointment of Ambarish Shah as Chief Technology Officer	12-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen DiaMedica Therapeutics Inc.

Aandelen

DMAC

CA25253X2077

Andere talen

Filters